Conclusion

Allergic rhinitis is a common disease that affects adults. It generates $2 to $5 billion in health expenditures yearly, impairs quality of life, and decreases work and school attendance. There are various treatments to manage this disease. Treatment is effective and safe and, therefore, a prime target for pharmacist prescriptive protocols. Educating and empowering pharmacists to appropriately screen and assess individuals with allergic rhinitis can improve patient access to care and prevent adverse outcomes.

Get Started with Scripted

Please complete the following fields

A text message will be sent to your phone to begin your Intake Form

Artboard 1 копия 6@3x


Answer these quick questions and we'll text you a link to your intake form.